These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34719118)

  • 1. Brain metabolic and microstructural alterations associated with hepatitis C virus infection, autoimmune hepatitis and primary biliary cholangitis.
    Reichardt JL; Dirks M; Wirries AK; Pflugrad H; Nösel P; Haag K; Lanfermann H; Wedemeyer H; Potthoff A; Weissenborn K; Ding XQ
    Liver Int; 2022 Apr; 42(4):842-852. PubMed ID: 34719118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychiatric symptoms in hepatitis C patients resemble those of patients with autoimmune liver disease but are different from those in hepatitis B patients.
    Dirks M; Haag K; Pflugrad H; Tryc AB; Schuppner R; Wedemeyer H; Potthoff A; Tillmann HL; Sandorski K; Worthmann H; Ding X; Weissenborn K
    J Viral Hepat; 2019 Apr; 26(4):422-431. PubMed ID: 30120896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis.
    Ma ZH; Wang XM; Wu RH; Hao DL; Sun LC; Li P; Niu JQ
    World J Gastroenterol; 2022 Oct; 28(39):5764-5783. PubMed ID: 36338890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
    PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-based metabolomic signature: An important tool for the diagnosis and study of pathogenesis of autoimmune hepatitis.
    Dimou A; Zachou K; Kostara C; Azariadis K; Giannoulis G; Lyberopoulou A; Bairaktari E; Dalekos GN
    Hepatology; 2024 Aug; 80(2):266-277. PubMed ID: 38305739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
    Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
    Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
    Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
    J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG and IgM Immunohistochemistry in Primary Biliary Cholangitis (PBC) and Autoimmune Hepatitis (AIH) Liver Explants.
    Hsu M; Ju JY; Pearson MM; Yu L; Swanson PE; Yeh MM
    Am J Clin Pathol; 2022 Dec; 158(6):770-773. PubMed ID: 36048887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
    Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy.
    Bokemeyer M; Ding XQ; Goldbecker A; Raab P; Heeren M; Arvanitis D; Tillmann HL; Lanfermann H; Weissenborn K
    Gut; 2011 Mar; 60(3):370-7. PubMed ID: 20926642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis.
    Lamba M; Ngu JH; Stedman CAM
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):573-579.e1. PubMed ID: 32526342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis.
    Kobayashi M; Kakuda Y; Harada K; Sato Y; Sasaki M; Ikeda H; Terada M; Mukai M; Kaneko S; Nakanuma Y
    World J Gastroenterol; 2014 Apr; 20(13):3597-608. PubMed ID: 24707143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes.
    Park Y; Cho Y; Cho EJ; Kim YJ
    Clin Mol Hepatol; 2015 Jun; 21(2):150-7. PubMed ID: 26157752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.
    Martínez Casas OY; Díaz Ramírez GS; Marín Zuluaga JI; Santos Ó; Muñoz Maya O; Donado Gómez JH; Restrepo Gutiérrez JC
    Gastroenterol Hepatol; 2018 Nov; 41(9):544-552. PubMed ID: 30017212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis.
    Yang F; Wang Q; Wang Z; Miao Q; Xiao X; Tang R; Chen X; Bian Z; Zhang H; Yang Y; Sheng L; Fang J; Qiu D; Krawitt EL; Gershwin ME; Ma X
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):114-23. PubMed ID: 26411425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.
    Landi A; Weismuller TJ; Lankisch TO; Santer DM; Tyrrell DL; Manns MP; Houghton M
    J Interferon Cytokine Res; 2014 Mar; 34(3):204-14. PubMed ID: 24168449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases.
    Wei Q; Jiang Y; Xie J; Yang M; Zhang Y; Wu Z; Chen S; Liao Z; Lin Z; Gu J
    Clin Rheumatol; 2020 Aug; 39(8):2425-2432. PubMed ID: 32103375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features.
    Wen M; Men R; Fan X; Shen Y; Ni P; Hu Z; Yang L
    Dig Dis; 2021; 39(4):366-374. PubMed ID: 33238269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease.
    Yamamoto K; Terada R; Okamoto R; Hiasa Y; Abe M; Onji M; Tsuji T
    J Gastroenterol; 2003; 38(1):52-9. PubMed ID: 12560922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.